Clinical Trial Update: Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) [Phase 4]

View source ↗

Summary

Phase 4 trial reports on the efficacy and safety of Loratadine-Betamethasone oral solution for severe perennial allergic rhinitis in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• Loratadine (Loratadine)
• betamethasone (betamethasone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rhinitis | Phase 4 | Status: COMPLETED